HiSiaddi is an innovative foreign trade service provider driven by both technology commercialization and export business. We have established a "1+2+3+4=1" service system and can supply BINAP sourced directly from well-known original manufacturers worldwide. As a foreign trade enterprise with in-house R&D capabilities, HiSiaddi has conducted multiple rounds of on-site inspections of BINAP manufacturers through technical cooperation with factories, possessing objective and in-depth insights into different brands. We regularly analyze BINAP manufacturers for clients to help them select matching products. Below is a brand recommendation case.
Please contact HiSiaddi customer service if you require further brand and model comparative analysis.
The client is a high-end pharmaceutical CDMO based in Munich, Germany, specializing in custom production of anti-cancer and anti-viral API serving the world’s top 20 pharmaceutical enterprises, with full FDA, EMA and GMP certification, representing a typical technology-driven mid-to-high-end client. The client purchases 80 kg of high-purity chiral BINAP (R/S configurations) annually for core chiral catalytic reactions, having long sourced Takasago (Japan) products before planning to expand Chinese suppliers in 2025 amid a 25% price hike and extended lead time of 12 weeks.
Client Pain Points: The client lacks familiarity with China’s BINAP brand landscape, technical tiers and model differences. After contacting five leading domestic manufacturers (Runyu, Funokang, Jixinyibang, Yuanda, Kelaman), each factory only promoted its own products while emphasizing self-advantages without objective commentary on competitors’ technical strengths and applicable scenarios. This deprived the client of horizontal comparison references, creating difficulties in model selection and triggering quality risk concerns that stalled procurement. The client entrusted HiSiaddi with neutral brand evaluation and product selection solutions.
As a European high-end client relying long on Japanese and Korean imports, the client has no understanding of China’s three-tier BINAP industry structure (top-tier mid-high-end, mid-tier, entry-level). It cannot identify technical gaps among brands in purity, chiral resolution, impurity control and pharmaceutical-grade compliance, risking misguidance by one-sided manufacturer marketing.
The five manufacturers are mainstream domestic BINAP producers yet adopt a "self-promotion, no competitor evaluation" strategy:
· Runyu: Highlights leading chiral resolution and stable ee values without mentioning Funokang’s ultra-high-purity purification advantages;
· Funokang: Markets 99.95% ultra-high purity and low heavy metals without acknowledging Runyu’s cost-effective industrial-grade products;
· Jixinyibang: Emphasizes customizable particle size and flexible production without comparing Kelaman’s research-grade quality;
· Yuanda: Stresses large production capacity and fast lead times without disclosing its lower purity versus top-tier brands;
· Kelaman: Focuses on small-batch research-grade production and strict impurity control without mentioning high mass production costs.
The client lacks horizontal comparison data, applicable scenario analysis and real client case references for decision-making, fearing post-procurement risks including substandard purity, unstable chiral configurations and excess impurities that disrupt pharmaceutical production compliance.
Clear client requirements: purity ≥99.8%, ee value ≥99.5%, heavy metals ≤0.5 ppm, moisture ≤100 ppm, complete GMP/REACH/COA documentation, compatibility with pharmaceutical-grade catalytic reactions, rejection of low-end industrial-grade products, and locking mid-to-high-end brands with mature models balancing technical compliance, stable supply and cost optimization.
Based on seven core dimensions (purity, chiral resolution, impurity control, compliance documentation, production capacity & lead time, applicable scenarios, price range), HiSiaddi conducted blind neutral testing, factory on-site verification and downstream client research across five brands and mainstream models to generate an objective comparison report with core details as follows:
1.
Xinxiang Runyu New Materials (Brand: Runyu) – Mid-to-High-End Leader, Chiral Resolution Benchmark Core Advantages: Top-tier domestic chiral resolution technology, stable ee value ≥99.6%, strong mass production capacity (monthly output 50 kg), complete pharmaceutical-grade compliance; Main Models:
2.
o R-BINAP-998: Purity 99.8%, ee value 99.6%, heavy metals ≤0.5 ppm, flagship pharmaceutical-grade model;
o S-BINAP-995: Purity 99.5%, ee value 99.5%, for general asymmetric catalysis;
o rac-BINAP-990: Purity 99.0%, industrial-grade racemate with cost advantages; Applicable Scenarios: Pharmaceutical API, high-end chiral catalysis, processes with strict ee value requirements; Price Range: Mid-to-high-end (20% lower than Japanese equivalents).
3.
Baoji Funokang Industrial (Brand: Funokang) – Ultra-High-Purity Benchmark, Leading Impurity Control Core Advantages: Pioneering ultra-high-purity purification technology, purity up to 99.95%, heavy metals ≤0.3 ppm, thorough removal of trace impurities; Main Models:
4.
o FNK-R-BINAP-9995: Purity 99.95%, ee value 99.7%, heavy metals ≤0.3 ppm, flagship ultra-pure pharmaceutical grade;
o FNK-R-BINAP-998: Purity 99.8%, ee value 99.6%, general high-purity grade;
o FNK-rac-BINAP-992: Purity 99.2%, high-purity industrial grade; Applicable Scenarios: High-end anti-cancer & anti-viral drugs, catalytic reactions sensitive to trace impurities; Price Range: High-end (slightly higher than Runyu, 15% lower than Japanese equivalents).
5.
Wuhan Jixinyibang (Brand: Jixinyibang) – Mid-Tier Customization, Flexible Production Strength Core Advantages: Customizable particle size control (5–50 μm adjustable), flexible small-batch production, moderate pricing; Main Models:
6.
o JXYB-R-BINAP-995: Purity 99.5%, ee value 99.4%, customizable particle size variant;
o JXYB-rac-BINAP-990: Purity 99.0%, customizable industrial grade; Applicable Scenarios: Fine chemicals with moderate purity requirements, general pharmaceutical intermediates requiring specific particle sizes; Price Range: Mid-tier with high cost performance.
7.
Guangzhou Yuanda New Materials (Brand: Yuanda) – Entry-Level Mass Production, Fast Lead Times Core Advantages: Large monthly capacity (100 kg), short lead time (2 weeks), lowest pricing; Main Models:
8.
o YD-rac-BINAP-990: Purity 99.0%, no ee value requirements, primary industrial-grade product;
o YD-R-BINAP-992: Purity 99.2%, ee value 99.0%, entry-level chiral variant; Applicable Scenarios: Industrial catalysis, general fine chemicals with relaxed purity standards; Price Range: Entry-level (lowest market price).
9.
Shanghai Kelaman Reagent (Brand: Kelaman) – Research-Grade Small-Batch, Rigorous Quality Control Core Advantages: Research-grade quality control, small-batch customization (1–5 kg), comprehensive impurity testing, compatible with university/pharma R&D; Main Models:
10.
o KLM-R-BINAP-998: Purity 99.8%, ee value 99.6%, high-purity research grade;
o KLM-S-BINAP-995: Purity 99.5%, ee value 99.5%, dedicated for R&D; Applicable Scenarios: New drug R&D, lab/pilot scale trials, scientific research projects; Price Range: High-end (premium pricing for small batches).
· Tier 1 (Mid-to-High-End, Compatible with Pharmaceutical Grade): Runyu, Funokang (qualified technology, complete compliance, stable supply, matching German client demands);
· Tier 2 (Mid-Tier, General Fine Chemicals): Jixinyibang (strong customization but slightly insufficient purity, unfit for pharmaceutical-grade production);
· Tier 3 (Entry-Level, Industrial Grade): Yuanda, Kelaman (Yuanda fails purity standards; Kelaman lacks mass production capacity, both incompatible).
Aligning with the client’s five core requirements (pharmaceutical-grade purity, stable chiral performance, low impurities, complete compliance, stable mass supply), HiSiaddi eliminated mid-tier and entry-level brands, focusing exclusively on Tier 1 with two top-tier brands and three core models, clarifying applicable scenarios and strengths:
Recommended Model: R-BINAP-998 Core Advantages:
· Purity 99.8%, ee value 99.6%, fully meeting pharmaceutical-grade catalytic standards;
· Heavy metals ≤0.5 ppm, moisture ≤90 ppm, compliant with USP standards;
· Stable monthly capacity (50 kg), 4-week lead time matching annual 80 kg demand;
· Complete GMP, REACH, COA and DMF documentation with EMA filing qualification;
· 20% cost reduction versus Japanese products, optimal overall cost performance.
Recommended Models: FNK-R-BINAP-9995 (Ultra-Pure Flagship), FNK-R-BINAP-998 (General High-Purity) Core Advantages:
· FNK-R-BINAP-9995: Purity 99.95%, ee value 99.7%, heavy metals ≤0.3 ppm, for high-end anti-cancer drug production with impurity control exceeding industry standards;
· FNK-R-BINAP-998: Purity 99.8%, ee value 99.6%, equivalent grade to Runyu as alternative backup;
· Complete removal of trace impurities (residual solvents, halogens), passing FDA impurity limit audits;
· Full SGS test reports and batch traceability files satisfying high-end API filing requirements.
· Eliminate low-tier brands: Yuanda’s insufficient purity and Kelaman’s limited mass production capacity cannot meet stability and compliance standards for pharmaceutical-grade manufacturing;
· Focus on Tier 1: Runyu and Funokang are China’s only two manufacturers capable of stable mass production of pharmaceutical-grade BINAP with compliant technology, documentation and supply chains;
· Tiered model matching:
1. Conventional API production: Runyu R-BINAP-998 (optimal comprehensive performance & cost efficiency);
2. High-end anti-cancer/anti-viral drug production: Funokang FNK-R-BINAP-9995 (ultra-low impurities for highly sensitive catalytic reactions);
3. Backup general-purpose option: Funokang FNK-R-BINAP-998 (equivalent grade alternative for supply redundancy).
The client highly recognized HiSiaddi’s neutral, data-driven brand evaluation report, stating it "broke manufacturer information barriers, clearly visualized technical gaps and applicable scenarios across brands, resolving core selection pain points". Final procurement decision:
· Primary Procurement: Runyu R-BINAP-998 (60 kg/year) for conventional API production;
· High-End Line Procurement: Funokang FNK-R-BINAP-9995 (20 kg/year) for anti-cancer drug production lines;
· First Batch Order: 30 kg (20 kg Runyu + 10 kg Funokang), 4-week lead time.
Full testing upon first batch arrival:
· Runyu R-BINAP-998: Purity 99.82%, ee value 99.65%, heavy metals 0.4 ppm, all indicators qualified;
· Funokang FNK-R-BINAP-9995: Purity 99.96%, ee value 99.72%, heavy metals 0.25 ppm, exceeding contracted standards. Production verification after introduction to API lines showed catalytic efficiency and product chiral purity matching Japanese imported materials, fully compatible with pharmaceutical-grade manufacturing with zero quality defects.
The client’s procurement director commented: "As a high-end pharmaceutical enterprise, we prioritize authentic, neutral information over manufacturers’ self-promotion. HiSiaddi clarified China’s BINAP brand landscape and accurately recommended brands and models matching our production requirements, eliminating selection risks. Products fully meet quality standards while cutting costs by 18%, making HiSiaddi a trustworthy strategic partner." Subsequent cooperation: The client awarded HiSiaddi full agency rights for its annual 80 kg BINAP order, entrusting additional high-end customization demands including S-BINAP and sulfonated BINAP to HiSiaddi for integrated solutions covering brand selection, technical coordination, quality supervision and compliance services. A 3-year framework cooperation agreement was signed.
Core pain point of high-end clients: Blank awareness of domestic Chinese brands, information asymmetry from self-biased manufacturer marketing, demand for neutral selection references, prioritizing precise matching, stable supply and complete compliance over low pricing. HiSiaddi Core Value: Act as neutral technical consultants rather than brand salesmen, breaking information barriers through full-dimensional evaluation and tiered recommendations aligned with client demands to mitigate selection risks and build trust. Core Brand Selection Logic: Mid-to-high-end clients must focus on Tier 1 brands with qualified technology, complete compliance and stable supply, matching models to application scenarios (conventional/high-end) to balance quality, cost and stability. Industry Insight: Providing professional, neutral, data-driven brand evaluation and product selection services differentiates HiSiaddi from ordinary trading companies, serving as core competitiveness to penetrate high-end client supply chains and realize long-term partnerships.
Please contact HiSiaddi customer service if you require further brand and model comparative analysis.
+86-13120989737 
info@hisiaddi.com 
English
